When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory. Accurately determining a company’s long-term prospects isn’t easy, especially when sentiment is weak. That’s where StockStory comes in - to help you find attractive investment candidates backed by unbiased research. Keeping that in mind, here are three stocks where the outlook is warranted and some alternatives with better fundamentals. DocuSign (DOCU) Consensus Price Target: $91.74 (1.1% implied return) Founded by Seattle-based entrepreneur Tom Gonser, DocuSign (NASDAQ:DOCU) is the pioneer of e-signature and offers software as a service that allows people and organisations to sign legally binding documents electronically. Why Are We Hesitant About DOCU? Customers had second thoughts about committing to its platform over the last year as its average billings growth of 6.6% underwhelmed Net revenue retention rate of 99.8% shows it has a tough time retaining customers Extended payback periods on sales investments suggest the company’s platform isn’t resonating enough to drive efficient sales conversions DocuSign’s stock price of $90.72 implies a valuation ratio of 6.3x forward price-to-sales. Check out our free in-depth research report to learn more about why DOCU doesn’t pass our bar. Guidewire (GWRE) Consensus Price Target: $210.72 (-1.5% implied return) Founded by two individuals involved in the development of leading procurement software Ariba, Guidewire (NYSE:GWRE) offers insurance companies a software-as-a-service platform to help sell their products and manage their workflows. Why Is GWRE Not Exciting? Sales trends were unexciting over the last three years as its 12.4% annual growth was below the typical software company High servicing costs result in a relatively inferior gross margin of 61.4% that must be offset through increased usage Extended payback periods on sales investments suggest the company’s platform isn’t resonating enough to drive efficient sales conversions Guidewire is trading at $213.99 per share, or 14.5x forward price-to-sales. If you’re considering GWRE for your portfolio, see our FREE research report to learn more. Sherwin-Williams (SHW) Consensus Price Target: $377.75 (4.1% implied return) Widely known for its success in the paint industry, Sherwin-Williams (NYSE:SHW) is a manufacturer of paints, coatings, and related products. Why Does SHW Give Us Pause? Absence of organic revenue growth over the past two years suggests it may have to lean into acquisitions to drive its expansion Anticipated sales growth of 2.5% for the next year implies demand will be shaky Free cash flow margin shrank by 8.5 percentage points over the last five years, suggesting the company is consuming more capital to stay competitive Story Continues At $362.99 per share, Sherwin-Williams trades at 29.6x forward P/E. Read our free research report to see why you should think twice about including SHW in your portfolio, it’s free. Stocks We Like More Market indices reached historic highs following Donald Trump’s presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth. While this has caused many investors to adopt a "fearful" wait-and-see approach, we’re leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 176% over the last five years. Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today for free. View Comments
3 Unpopular Stocks Skating on Thin Ice
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...